Cannabis potentially reduces recurrent episodes of hereditary angioedema
Abstract
Hereditary angioedema (HAE) is a rare disease affecting an estimated 1 in 50,000 individuals in the United States.The clinical presentation involves recurrent episodes of angioedema, without urticaria or pruritus, in mucosal tissues of various organ systems. We present a case of HAE type II with concomitant use of cannabis that possibly decreased the frequency of his episodes of angioedema. Recent studies indicate that cannabis has an important role in regulating innate immunity and inflammatory responses through the inhibition of pro-inflammatory cytokines and upregulation of anti-inflammatory cytokines. These effects might reduce episodes of angioedema, but more research is needed.Downloads
References
Lumry WR. Overview of epidemiology, pathophysiology, and disease progression in hereditary angioedema. Am J Manag Care 2013 Jun; 19(7 Suppl):s103-10.
Zuraw BL. Hereditary angioedema. N Engl J Med 2008; 359: 1027-1036.
Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med 2001 Nov 12; 161(20):2417-29.
Nzeako UC, Longhurst HJ. Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema. Eur J Gastroenterol Hepatol 2012; 24:353.
Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy 2014; 69:602.
Frenkel A, Roy-Shapira A, Evgeni B, Leonid K, Borer A, Klein M. Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis. Case Reports Immunol 2015; 2015:780824.
Rom S, Persidsky Y. Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. J Neuroimmune Pharmacol 2013 Jun; 8(3):608-20.
Rajesh M1, Mukhopadhyay P, Bátkai S, Haskó G, Liaudet L, Drel VR, Obrosova IG, Pacher P. Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Am J Physiol Heart Circ Physiol 2007 Jul; 293(1):H610-9.
Ramirez SH, Haskó J, Skuba A, Fan S, Dykstra H, McCormick R, Reichenbach N, Krizbai I, Mahadevan A, Zhang M, Tuma R, Son YJ, Persidsky Y. Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions. J Neurosci 2012 Mar 21; 32(12):4004-16.
El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol. 2006 Jan; 168(1):235-44.
